Rapamycin

How it works

Inhibits the mTOR pathway involved in cell growth and metabolism. FDA-approved as an immunosuppressant; its use for longevity/healthspan is investigational and off-label.

Known risks

Immunosuppression and infection risk, mouth sores, metabolic changes (lipids, glucose); longevity-context risk/benefit is not established.

Contraindications

Active infection; pregnancy; known hypersensitivity; settings where immunosuppression is unsafe.

Drug interactions

Levels strongly affected by CYP3A4/P-gp inhibitors and inducers; many clinically significant interactions.

Rapamycin is provided here for education only — it is not currently offered through Diadara. See what we do offer →